Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Montelukast Sodium NDC 43063-381 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 01

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 01

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 02

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 02

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 03

13ed8fe9 b0a7 4906 81a0 c2e253a3f180 03

This appears to be a chart or graph displaying mean percent change from baseline at different weeks (2, 6, 12, and 15) during treatment with either a placebo or montelukast sodium. Without more context or information, it is difficult to provide a more specific description or interpretation of the data.*

image - 43063381

image - 43063381

This is a description of a medication called Montelukast Sodium Chew. It comes in a pink oval shape and in three packages, each containing 30 chewable tablets with 4mg strength. The medication has a LOT number, expiration date (03/2020) and a NDC code (43063- 381-30). The package insert provides instructions for dosage and storage. The user should contact a doctor in case of side effects and report to the FDA as required. The packaging should be kept out of the reach of children. The document also lists an Organoleptic marking of 1079 A MG on the tablets.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.